Presentation + Paper
9 September 2019 Direct detection of cancer biomarkers using plasmonics-based Inverse Molecular Sentinel (iMS) nanobiosensors
Bridget M. Crawford, Hsin-Neng Wang, Michelle L. Bowie, Victoria L. Seewaldt, Tuan Vo-Dinh
Author Affiliations +
Abstract
Development of simple techniques for detection of nucleic acids is essential for clinical diagnostics. MicroRNA (miRNA) have been identified as potential biomarkers in early detection of various diseases, including esophageal adenocarcinoma (EAC) and Barrett’s esophagus (BE). However, these small molecules have not been adopted into clinical practice because of challenging aspects in the lab. The technology described herein is a label-free nanoprobe referred to as “inverse molecular sentinel” (iMS) for gastrointestinal cancer diagnosis using surface-enhanced Raman scattering (SERS) detection. The results of this study provide evidence supporting the robust iMS method for miRNA sensing without the need for PCR.
Conference Presentation
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Bridget M. Crawford, Hsin-Neng Wang, Michelle L. Bowie, Victoria L. Seewaldt, and Tuan Vo-Dinh "Direct detection of cancer biomarkers using plasmonics-based Inverse Molecular Sentinel (iMS) nanobiosensors", Proc. SPIE 11087, Biosensing and Nanomedicine XII, 1108702 (9 September 2019); https://doi.org/10.1117/12.2529832
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Nanoprobes

Cancer

Raman spectroscopy

Surface enhanced Raman spectroscopy

Raman scattering

Diagnostics

Nanoparticles

Back to Top